All the latest news and stories about Alzheimer's disease, dementia, and the brain.
Information for Canadians about lecanemab’s initial U.S. FDA approval
January 11, 2023
On January 6, 2023, the U.S. Food and Drug Administration approved the new drug Leqembi (also known as lecanemab) for treatment of early Alzheimer’s disease. Here’s what people in Canada might want to know about it.
![Part of an intravenous (IV) drip](/sites/default/files/styles/teaser/public/2023-01/iv-drip-medium-crop.jpg?itok=3-H5owEn)
New Ontario Dementia Care Alliance Launches to Create a More Dementia-Friendly Province
Ontario
December 21, 2022